ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2024

Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.

Yuko Kanbayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.